Cargando…

The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients

Detalles Bibliográficos
Autor principal: Zeng, Defu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629734/
https://www.ncbi.nlm.nih.gov/pubmed/37941918
http://dx.doi.org/10.1097/BS9.0000000000000171
_version_ 1785132019158614016
author Zeng, Defu
author_facet Zeng, Defu
author_sort Zeng, Defu
collection PubMed
description
format Online
Article
Text
id pubmed-10629734
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106297342023-11-08 The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients Zeng, Defu Blood Sci Commentary Lippincott Williams & Wilkins 2023-09-08 /pmc/articles/PMC10629734/ /pubmed/37941918 http://dx.doi.org/10.1097/BS9.0000000000000171 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the Chinese Medical Association (CMA) and Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (IHCAMS). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Commentary
Zeng, Defu
The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
title The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
title_full The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
title_fullStr The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
title_full_unstemmed The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
title_short The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
title_sort opposite impact of janus kinase inhibitor ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute gvhd recipients
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629734/
https://www.ncbi.nlm.nih.gov/pubmed/37941918
http://dx.doi.org/10.1097/BS9.0000000000000171
work_keys_str_mv AT zengdefu theoppositeimpactofjanuskinaseinhibitorruxolitinibonthefunctionofbonemarrowmesenchymalstemcellsandimmunecellsinacutegvhdrecipients
AT zengdefu oppositeimpactofjanuskinaseinhibitorruxolitinibonthefunctionofbonemarrowmesenchymalstemcellsandimmunecellsinacutegvhdrecipients